1. Home
  2. LGIH vs GHRS Comparison

LGIH vs GHRS Comparison

Compare LGIH & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LGI Homes Inc.

LGIH

LGI Homes Inc.

HOLD

Current Price

$40.56

Market Cap

1.1B

ML Signal

HOLD

Logo GH Research PLC

GHRS

GH Research PLC

HOLD

Current Price

$21.54

Market Cap

947.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LGIH
GHRS
Founded
2003
2018
Country
United States
Ireland
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
947.2M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
LGIH
GHRS
Price
$40.56
$21.54
Analyst Decision
Hold
Strong Buy
Analyst Count
5
8
Target Price
$75.90
$41.38
AVG Volume (30 Days)
415.7K
255.2K
Earning Date
04-28-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.09
N/A
Revenue
$1,705,504,000.00
N/A
Revenue This Year
$2.32
N/A
Revenue Next Year
$17.94
N/A
P/E Ratio
$487.56
N/A
Revenue Growth
N/A
N/A
52 Week Low
$33.55
$10.67
52 Week High
$69.42
$24.66

Technical Indicators

Market Signals
Indicator
LGIH
GHRS
Relative Strength Index (RSI) 39.15 60.68
Support Level $34.71 $12.41
Resistance Level $41.50 $22.88
Average True Range (ATR) 2.33 1.33
MACD -0.64 -0.07
Stochastic Oscillator 1.03 67.96

Price Performance

Historical Comparison
LGIH
GHRS

About LGIH LGI Homes Inc.

LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company's current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under the LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. The company has seven operating segments: West, Northwest, Central, Midwest, Florida, Southeast, and Mid-Atlantic. The majority of the revenue is generated from the Central division segment.

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

Share on Social Networks: